Cargando…
Subconjunctival administration of low-dose murine allogeneic mesenchymal stromal cells promotes corneal allograft survival in mice
BACKGROUND: Systemic administration of mesenchymal stromal cells (MSCs) has been efficacious in many inflammatory disease settings; however, little data are available on the potential immunomodulatory effects following local MSC administration in the context of corneal transplantation. The purpose o...
Autores principales: | Treacy, Oliver, Lynch, Kevin, Murphy, Nick, Chen, Xizhe, Donohoe, Ellen, Canning, Aoife, Lohan, Paul, Shaw, Georgina, Fahy, Gerry, Ryan, Aideen E., Ritter, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025388/ https://www.ncbi.nlm.nih.gov/pubmed/33823917 http://dx.doi.org/10.1186/s13287-021-02293-x |
Ejemplares similares
-
Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation
por: Lohan, Paul, et al.
Publicado: (2018) -
TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo
por: Lynch, Kevin, et al.
Publicado: (2020) -
Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?
por: Lohan, Paul, et al.
Publicado: (2017) -
Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012) -
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
por: Goktas, Sertan, et al.
Publicado: (2014)